News Articles on 'Clinical Immunology'

Back to All Specialties


CD63 Ratio May Predict Allergic Reaction Severity in Peanut Food Challenge

A decision rule determined by using a Challenge Severity Score (CSS) may help predict the risk for severe reaction during peanut oral food challenges (OFC), according to the results of a study published in the Annals of Allergy, Asthma & Immunology.

Source: Clinical Advisor
Published: 12 Jun 2018

Aimmune Therapeutics to Present Data on Peanut Allergy at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2018

Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that it will present data on peanut allergy at the European Academy of Allergy and Clinical Immunology ...

Source: Yahoo Finance
Published: 15 May 2018

Jain, Archana, MD

Internship (Internal Medicine), St. Francis Hospital, Evanston, IL, 2003-2004 Residency (Internal Medicine), St. Francis Hospital, Evanston, IL, 2004-2005 Clinical interests include inflammatory arthritis, SLE, vasculitides, inflammatory myopathies ...

Source: UAB
Published: 22 Feb 2018

DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology

MONTROUGE, France--(BUSINESS WIRE)--DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced the publication of 12-month results from CoFAR6, a Consortium of Food Allergy Research (CoFAR) study sponsored by the ...

Source: Business Wire
Published: 27 Oct 2016

ALLERGY & IMMUNOLOGY INFORMATION CENTER

Researchers developed a predictive algorithm to identify individuals with a higher risk for severe reactions to the standardized peanut oral food challenge. Early vaccination of autologous hemopoietic stem-cell transplant (auto-HSCT) recipients during the ...

Source: Clinical Advisor
Published: 19 Dec 2017

Award for Clinical Lab Immunology

Immunologist at The Children's Hospital of Philadelphia Receives National Award in Clinical Laboratory Immunology Philadelphia, Pa. -- Steven D. Douglas, M.D., director of the Section of Immunology and of the Clinical Immunology Laboratories at The ...

Source: Newswise
Published: 23 Aug 2016

Pursuing Novel Pathways in Immunology: Merck KGaA, Darmstadt, Germany Presents New Clinical Data at 2017 ACR/ARHP Annual Meeting

- Company to present 11 abstracts and highlight momentum of its clinical programs in systemic lupus erythematosus (SLE), osteoarthritis (OA), rheumatoid arthritis (RA) and fibrotic diseases - Late-breaking Phase II data provide insights into potential ...

Source: Yahoo Finance
Published: 20 Oct 2017

Clinical and Translational Immunology

Brought to you by the editorial team of Immunology & Cell Biology, Clinical & Translational Immunology is a new Open Access, fully peer-reviewed journal devoted to publishing the latest and most exciting advances in biomedical research for scientists and ...

Source: Phys.org
Published: 28 Apr 2017

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis

Correction to: Clinical & Translational Immunology (2017) 6, e126; doi:10.1038/cti.2016.87; published online 20 January 2017. The volume number in the PDF of the above paper was published incorrectly. It should be 6 instead of 5. This has now been ...

Source: Nature
Published: 16 Jun 2017

Aimmune Therapeutics Presents Clinical Data on Phase 3 Screening and Phase 2 Adherence for AR101 for Peanut Allergy at the 2017 American Academy of Allergy, Asthma & Immunology ...

BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, announced clinical data presented today at the 2017 American Academy of Allergy, Asthma ...

Source: Business Wire
Published: 06 Mar 2017

1 High-Yield Blue Chip Set To Soar And 1 You Should Ignore

For example, in immunology, the Psoriasis drug risankizumab has shown ... The drug just scored a major win in a clinical trial by achieving a 50% or more improvement in symptoms at 12 weeks in 56% of patients. That's compared to the standard of care ...

Source: Seeking Alpha
Published: 21 Jun 2018

Annual Report 2018: State of the Bio Industry

Clinical trials using biomarkers to stratify patients susceptible ... infectious diseases, diabetes, and immunology among others, which have shown high acceptability across regions; • Capturing investment opportunities through partnerships with niche ...

Source: PharmaLive
Published: 11 Jun 2018

The evolution of clinical immunology and allergy in Australia

In this, the 50th year of the formal promulgation of the Clonal Selection Theory, it is appropriate to reflect in broad terms on the impact Burnet and Fenner's 1, 2 work has had on Australian Immunology ... that the clinical specialty of immunology ...

Source: Nature
Published: 26 Nov 2007

New Tools for Depression

“I lost count of the number of lunches I had with drug company executives, but the answer was always no,” says Miller, who also serves as the director of the Immunology Program ... director of the depression clinical and research program at ...

Source: Proto
Published: 18 Jun 2018

Current Opinion in Allergy and Clinical Immunology Selected for Inclusion

Current Opinion in Allergy and Clinical Immunology Selected for Inclusion in Index Medicus/MEDLINELWW's New Journal Accepted on First Submission For Immediate ReleaseContact: Kevin Anderer215-521-8467kanderer@LWW.com Philadelphia, PA, November 27, 2001 ...

Source: Newswise
Published: 28 Nov 2001

Celgene Corporation (CELG) Management Presents at 2018 Bernstein Strategic Decisions Conference (Transcript)

OTEZLA is our flagship drug in our immunology information organization for psoriasis ... and that has 2 large randomized Phase 3 trials that have profoundly important clinical efficacy safety advantages versus the current marketplace so the Phase 3 program ...

Source: Seeking Alpha
Published: 31 May 2018